Schizophrenia News and Research

Latest Schizophrenia News and Research

Errors in medication common on admission to mental health services, shows study

A recent study, published in the International Journal of Clinical Pharmacy, involving Aston University (UK), South Essex Partnership University NHS Foundation Trust (SEPT) and the University of East Anglia (UK) found medication errors were common on admission to mental health services.

16 Nov 2013

Study highlights major challenge faced by older adults with severe mental illnesses

Although older adults with serious mental illness didn't have more recorded physical illness and had fewer outpatient visits to primary care physicians, they made more medical emergency department visits and had considerably longer medical hospitalizations than older adults without mental illness according to a study conducted by researchers from the Regenstrief Institute and the Indiana University Center for Aging Research.

15 Nov 2013

Research could refine next generation of drugs to help treat dementia

A £1.1 million grant to understand how one of the brain's key neurotransmitters called 'acetylcholine' influences brain activity has been awarded to University of Bristol researchers. The Wellcome Trust award will help scientists understand more precisely how the release of acetylcholine is changing brain cell activity to influence memory and cognition.

15 Nov 2013

ACADIA Pharmaceuticals initiates pimavanserin Phase II trial in ADP patients

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has initiated a Phase II feasibility trial designed to examine the efficacy and safety of pimavanserin as a treatment for patients with Alzheimer's disease psychosis.

15 Nov 2013

Gray matter changes reflect psychosis burden

Changes in gray matter volume may be associated with psychosis burden rather than clinical diagnosis, research suggests.

14 Nov 2013

Researchers generate most complete genome sequences from single cells and individual neurons

Researchers led by bioengineers at the University of California, San Diego have generated the most complete genome sequences from single E. coli cells and individual neurons from the human brain. The breakthrough comes from a new single-cell genome sequencing technique that confines genome amplification to fluid-filled wells with a volume of just 12 nanoliters.

14 Nov 2013

Switching focus underlies attention problems in schizophrenia

Impaired attention in patients with schizophrenia is related to difficulties in switching the focus of attention rather than in maintaining attention, researchers report.

13 Nov 2013

New view can give scientists better understanding of how antidepressants work in human brain

Research from Oregon Health & Science University's Vollum Institute, published in the current issue of Nature, is giving scientists a never-before-seen view of how nerve cells communicate with each other.

13 Nov 2013

Novel approach confirms dysfunctional energy production in schizophrenia

A method of directly assessing creatine kinase in the brain provides “direct and compelling” evidence for abnormal bioenergetics in the brains of patients with schizophrenia, say the study authors.

12 Nov 2013

Research reveals unexpected roles that sex hormones may play in cognitive function

Research released today demonstrates unexpected roles that sex hormones may play in the cognitive function of females, including memory and interpreting social cues.

12 Nov 2013

Pregnant women may transmit effects of stress to child by way of bacteria in vagina and placenta

Pregnant women may transmit the damaging effects of stress to their unborn child by way of the bacteria in their vagina and through the placenta, suggest new findings from two animal studies presented by researchers at the University of Pennsylvania at Neuroscience 2013, the annual meeting of the Society for Neuroscience.

12 Nov 2013

Researchers identify critical mechanism to improve survival and behavior of new brain cells

A specialized type of brain cell that tamps down stem cell activity ironically, perhaps, encourages the survival of the stem cells' progeny, Johns Hopkins researchers report.

11 Nov 2013

GW Pharmaceuticals starts Phase 1b/2a clinical trial for Recurrent Glioblastoma Multiforme

GW Pharmaceuticals plc a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today it has commenced a Phase 1b/2a clinical trial for the treatment of Recurrent Glioblastoma Multiforme.

11 Nov 2013

Genovate, ScinoPharm to jointly develop new-generation oral Hepatitis B drug Livepro

Genovate Biotechnology Co. Ltd. and ScinoPharm Taiwan Ltd. announced today that they have jointly developed the highly potent oral generic drug Livepro (Entecavir), representing a new generation of drugs for the treatment of Hepatitis B. It is expected to be commercially available by the end of the year in Taiwan, accounting for more than NT$2 billion (US$70 million) worth of market opportunity.

11 Nov 2013

Adherence to suicide risk assessment urged for schizophrenia patients

Many patients with schizophrenia who attempt suicide after hospital discharge missed out on a pre-discharge suicide risk assessment, shows a study from Denmark. .

8 Nov 2013

Brain & Behavior Research Foundation announces recipients of NARSAD Investigator Grants

The Brain & Behavior Research Foundation (formerly known as NARSAD, the National Alliance for Research on Schizophrenia and Depression), under the direction of Dr. Jeffrey Borenstein, President & CEO, has announced the latest recipients of its NARSAD Distinguished Investigator Grants.

8 Nov 2013

Schizophrenia News and Research

Latest Schizophrenia News and Research

Errors in medication common on admission to mental health services, shows study

Study highlights major challenge faced by older adults with severe mental illnesses

Research could refine next generation of drugs to help treat dementia

ACADIA Pharmaceuticals initiates pimavanserin Phase II trial in ADP patients

Gray matter changes reflect psychosis burden

Researchers generate most complete genome sequences from single cells and individual neurons

Switching focus underlies attention problems in schizophrenia

New view can give scientists better understanding of how antidepressants work in human brain

Novel approach confirms dysfunctional energy production in schizophrenia

Research reveals unexpected roles that sex hormones may play in cognitive function

Pregnant women may transmit effects of stress to child by way of bacteria in vagina and placenta

Researchers identify critical mechanism to improve survival and behavior of new brain cells

GW Pharmaceuticals starts Phase 1b/2a clinical trial for Recurrent Glioblastoma Multiforme

Genovate, ScinoPharm to jointly develop new-generation oral Hepatitis B drug Livepro

Adherence to suicide risk assessment urged for schizophrenia patients

Brain & Behavior Research Foundation announces recipients of NARSAD Investigator Grants

Schizophrenia patients fare well with outpatient care

Population genetic studies may have limited role in schizophrenia

Lack of neurocognitive gender differences in early psychosis

Metacognitive training complements antipsychotic therapy

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Schizophrenia News and Research

Latest Schizophrenia News and Research

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in